TRIB2 and acute myeloid leukemia: Consistent with this observation, a recent study uncovered an additional mechanism of chemoresistance in AML in which TRIB2 overexpression confers resistance to cytarabine, doxorubicin and daunorubicin, DNA intercalating agents which cause breakage of DNA strands and inhibition of DNA synthesis [70].